237 related articles for article (PubMed ID: 16412602)
1. The significance of one positive axillary node.
Kuijt GP; van de Poll-Franse LV; Roumen RM; van Beek MW; Voogd AC
Eur J Surg Oncol; 2006 Mar; 32(2):139-42. PubMed ID: 16412602
[TBL] [Abstract][Full Text] [Related]
2. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
3. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
4. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
5. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
6. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
[TBL] [Abstract][Full Text] [Related]
7. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
[TBL] [Abstract][Full Text] [Related]
8. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
[TBL] [Abstract][Full Text] [Related]
9. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
[TBL] [Abstract][Full Text] [Related]
10. The value of level III clearance in patients with axillary and sentinel node positive breast cancer.
Dillon MF; Advani V; Masterson C; O'Loughlin C; Quinn CM; O'Higgins N; Evoy D; McDermott EW
Ann Surg; 2009 May; 249(5):834-9. PubMed ID: 19387317
[TBL] [Abstract][Full Text] [Related]
11. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients.
Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Smith FP; Taghian A; Magnant C
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):40-4. PubMed ID: 16488555
[TBL] [Abstract][Full Text] [Related]
13. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
Alkuwari E; Auger M
Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
[TBL] [Abstract][Full Text] [Related]
15. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
16. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
[TBL] [Abstract][Full Text] [Related]
17. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
Laura S; Coombs NJ; Ung O; Boyages J
ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
[TBL] [Abstract][Full Text] [Related]
18. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
[TBL] [Abstract][Full Text] [Related]
19. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
